Innovating Works

H2020

Cerrada
HORIZON-JU-GH-EDCTP3-2023-01-02
Funding to successfully finalise EDCTP2-funded clinical trials that were negatively impacted by the COVID-19 pandemic
ExpectedOutcome:Project results are expected to contribute to the following outcomes:
Sólo fondo perdido 2.5M €
Europeo
Mostrando 41 al 54 de 54 resultados
CodeZERO: CO DESIGN OF E COMMERCE LAST MILE DELIVERY AND RETURN OPTIONS WITH ZERO EMISSIONS Professional Dietetics SpA tramitó un HORIZON EUROPE: HORIZON-CL5-2023-D6-01 CodeZERO is a three-year project aiming to co-create sustainable and zero-emission last-mile delivery and return solution for e-commerce tha...
2024-04-05 - 2027-05-31 | Financiado
TRA2026: Transport Research Arena 2026: Budapest KTI MAGYAR KOZLEKEDESTUDOMANYI ES LOGISZTIKAI INTEZET NONPROFIT KORLATOLT FELELOSSEGU TARSASAG tramitó un HORIZON EUROPE: HORIZON-CL5-2023-D6-01 The TRA2026 project aims to support the organisation of the TRA conference in Budapest in 2026 and deliver the related competitions. This pr...
2024-04-01 - 2026-09-30 | Financiado
STRATEGIC: Sustainable eThics Reviews of digital heAlth Technology dEsiGn In sub saharan afriCa RHEINISCHE FRIEDRICHWILHELMSUNIVERSITAT BONN tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2023-01 The STRATEGIC project aims to co-create responsible research and innovation approach that aligns with social-cultural values, principles, co...
2024-04-01 - 2027-03-31 | Financiado
CAPACITY 2023: CONSORTIUM FOR DEVELOPING REGULATORY CAPACITY FOR CLINICAL TRIALS USING GENE THERAPY PRODUCTS AND ST... UNIVERSIDADE DE COIMBRA tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2023-01 Gene therapy advancements have shown promise in treating chronic conditions like HIV and Sickle cell Anaemia and have the potential to great...
2024-03-22 - 2027-03-31 | Financiado
ASAAP-plus: Clinical evaluation of AntimalarialS tri-therapy with AtovAquone-Proguanil for treatment of uncompli... BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2023-01 Susceptibility to Artemisinin-based combination therapies (ACTs) currently remains high among the African Plasmodium falciparum population,...
2024-03-11 - 2025-12-31 | Financiado
DOLPHIN-3: Drug Optimisation in LMICs of Pregnant HIV women and their Infants temporary switch to CAB RPV long... UNIVERSITY OF CAPE TOWN tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2023-01 Sustained ART use is essential for achieving SDG3 by reducing HIV burden and promoting maternal and infant health. Ensuring consistent adher...
2024-03-07 - 2029-03-31 | Financiado
OPTIC-TB: OPTIMIZING THE IMPLEMENTATION AND SCALE-UP OF THE WHO TB TREATMENT DECISION ALGORITHMS FOR CHILDREN... HOGSKULEN PA VESTLANDET tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2023-01 Every year, about a million children under 15 years are diagnosed with Tuberculosis (TB) worldwide, and about a quarter die. However, over 6...
2024-03-07 - 2028-03-31 | Financiado
4-CAGE-TB: Fortifying the automated smartphone-based Cough Audio classification for rapid triaGE testing for tu... STELLENBOSCH UNIVERSITY tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2023-01 Tuberculosis (TB) is the single biggest infectious cause of death globally, a situation worsened by COVID-19. Revolutionary new TB triage te...
2024-03-06 - 2026-06-30 | Financiado
IMCI-PLUS: POINT OF CARE ULTRASOUND FOR PEDIATRIC LOWER RESPIRATORY TRACT INFECTIONS IN SUB-SAHARAN AFRICA IMCI-PLUS is an inter-disciplinary, Pan-African-EU research partnership, with emphasis on capacity strengthening and mutual learning, to imp...
2024-03-05 - 2028-09-30 | Financiado
The META Trial: PREVENTING AND DELAYING THE DEVELOPMENT OF DIABETES IN AFRICA A RANDOMISED PLACEBO CONTROLLED DOUB... FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2023-01 Diabetes is a common co-morbidity among people living with HIV. Since Oct 2021, we have been conducting a phase III randomised placebo-contr...
2024-03-05 - 2026-12-31 | Financiado
PEP4LEP 2.0: PEP4LEP 2.0 - Chemoprohylaxis for leprosy: comparing the effectiveness and feasibility of a communit... NEDERLANDSE STICHTING VOOR LEPRABESTRIJDING tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2023-01 BACKGROUND - Leprosy is a significant public health problem. Early detection, treatment, and prevention are crucial to reduce transmission a...
2024-03-04 - 2026-03-31 | Financiado
INTENSE-TBM-2: Intensified tuberculosis treatment to reduce the high mortality of tuberculous meningitis in HIV-inf... UNIVERSITE DE BORDEAUX tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2023-01 Tuberculosis (TB) remains a global health problem. The most lethal and disabling form of TB is tuberculous meningitis (TBM), with an estimat...
2024-03-04 - 2026-12-31 | Financiado
PROTECT: PReparing for Optimal Phase III/IV maTErnal Group B StreptococCal vaccine Trials in Africa (PROTECT) FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2023-01 Two vaccines designed for pregnant women, to protect their unborn infant, are entering late phase development and will prevent infections fr...
2024-02-27 - 2027-02-28 | Financiado
CCAM-ERAS: CCAM-Employment Realization through the Acquisition of Skills (CCAM-ERAS) MUCONSULT BV tramitó un HORIZON EUROPE: HORIZON-CL5-2023-D6-01 CCAM-ERAS aims to build towards the future and address the transition to connected, cooperative and automated mobility (CCAM) from a socio-e...
2024-02-16 - 2026-07-31 | Financiado